| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| zalutumumab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cancer of Head and Neck[MeSHID:D006258] |
1.79 | investigational,phase 3 | antagonist,antibody |
| zalutumumab | epidermal growth factor receptor | biotech | Successful target | TTD , drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cancer of Head and Neck[MeSHID:D006258] |
1.79 | investigational,phase 3 | antagonist |
| click here to return to the previous page | ||||||||